$AMBA
AMBARELLA INC

2015 Q2 Form 10-Q Financial Statement

#000156459015004907 Filed on June 08, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $71.01M $40.92M
YoY Change 73.54% 20.57%
Cost Of Revenue $25.10M $15.33M
YoY Change 63.75% 25.12%
Gross Profit $45.92M $25.60M
YoY Change 79.4% 17.99%
Gross Profit Margin 64.66% 62.55%
Selling, General & Admin $9.010M $6.755M
YoY Change 33.38% 30.99%
% of Gross Profit 19.62% 26.39%
Research & Development $16.58M $12.91M
YoY Change 28.41% 14.11%
% of Gross Profit 36.11% 50.45%
Depreciation & Amortization $367.0K $299.0K
YoY Change 22.74% 54.12%
% of Gross Profit 0.8% 1.17%
Operating Expenses $25.59M $19.67M
YoY Change 30.12% 19.39%
Operating Profit $20.33M $5.927M
YoY Change 242.92% 13.57%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $27.00K $49.00K
YoY Change -44.9% -1080.0%
Pretax Income $20.35M $5.976M
YoY Change 240.56% 14.61%
Income Tax $1.498M $716.0K
% Of Pretax Income 7.36% 11.98%
Net Earnings $18.85M $5.260M
YoY Change 258.44% 10.95%
Net Earnings / Revenue 26.55% 12.85%
Basic Earnings Per Share $0.61 $0.18
Diluted Earnings Per Share $0.56 $0.17
COMMON SHARES
Basic Shares Outstanding 31.10M 28.98M
Diluted Shares Outstanding 33.47M 31.76M

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $235.2M $155.6M
YoY Change 51.16% 49.19%
Cash & Equivalents $197.3M $129.5M
Short-Term Investments $37.90M $26.10M
Other Short-Term Assets $4.800M $4.200M
YoY Change 14.29% 40.0%
Inventory $25.80M $10.03M
Prepaid Expenses
Receivables $39.20M $21.31M
Other Receivables $0.00 $0.00
Total Short-Term Assets $305.0M $191.2M
YoY Change 59.54% 36.43%
LONG-TERM ASSETS
Property, Plant & Equipment $3.000M $2.950M
YoY Change 1.69% -0.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.928M $1.873M
YoY Change 2.94% -8.81%
Total Long-Term Assets $8.928M $6.083M
YoY Change 46.77% -0.43%
TOTAL ASSETS
Total Short-Term Assets $305.0M $191.2M
Total Long-Term Assets $8.928M $6.083M
Total Assets $313.9M $197.3M
YoY Change 59.14% 34.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.99M $13.41M
YoY Change 78.92% 34.25%
Accrued Expenses $15.34M $9.334M
YoY Change 64.38% -16.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $46.90M $28.01M
YoY Change 67.45% 10.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.600M $1.556M
YoY Change 2.83% 5.85%
Total Long-Term Liabilities $1.600M $1.556M
YoY Change 2.83% 5.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $46.90M $28.01M
Total Long-Term Liabilities $1.600M $1.556M
Total Liabilities $48.50M $29.56M
YoY Change 64.05% 10.17%
SHAREHOLDERS EQUITY
Retained Earnings $51.32M
YoY Change 104.07%
Common Stock $13.00K
YoY Change 8.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $265.4M $167.7M
YoY Change
Total Liabilities & Shareholders Equity $313.9M $197.3M
YoY Change 59.13% 34.89%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income $18.85M $5.260M
YoY Change 258.44% 10.95%
Depreciation, Depletion And Amortization $367.0K $299.0K
YoY Change 22.74% 54.12%
Cash From Operating Activities $24.80M $10.30M
YoY Change 140.78% 220.27%
INVESTING ACTIVITIES
Capital Expenditures $376.0K $224.0K
YoY Change 67.86% -61.31%
Acquisitions
YoY Change
Other Investing Activities -$500.0K -$26.40M
YoY Change -98.11%
Cash From Investing Activities -$800.0K -$26.60M
YoY Change -96.99% 4494.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.100M 2.400M
YoY Change 29.17% 109.42%
NET CHANGE
Cash From Operating Activities 24.80M 10.30M
Cash From Investing Activities -800.0K -26.60M
Cash From Financing Activities 3.100M 2.400M
Net Change In Cash 27.10M -13.90M
YoY Change -294.96% -467.43%
FREE CASH FLOW
Cash From Operating Activities $24.80M $10.30M
Capital Expenditures $376.0K $224.0K
Free Cash Flow $24.42M $10.08M
YoY Change 142.4% 282.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
741000
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1928000
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1902000
CY2015Q2 us-gaap Assets
Assets
313928000
CY2015Q1 us-gaap Assets
Assets
284284000
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
23990000
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
21036000
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15343000
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18699000
CY2015Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1306000
CY2015Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
748000
CY2015Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
132000
CY2014Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
126000
CY2015Q2 us-gaap Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
72000
CY2015Q1 us-gaap Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
92000
CY2015Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
187000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5976000
CY2015Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
198000
CY2015Q2 us-gaap Gross Profit
GrossProfit
45918000
CY2014Q2 us-gaap Gross Profit
GrossProfit
25596000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16583000
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12914000
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9010000
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6755000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
25593000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
19669000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
20325000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5927000
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
27000
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
49000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20352000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1498000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
716000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
18854000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
5260000
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31099081
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28976339
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33472309
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31763993
CY2015Q2 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss
-16000
CY2014Q2 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss
8000
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16000
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
8000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18838000
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5268000
CY2015Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
367000
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
299000
CY2015Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-7000
CY2014Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5482000
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2874000
CY2015Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
183000
CY2014Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
274000
CY2015Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-75000
CY2014Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3000
CY2015Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-987000
CY2014Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2468000
CY2015Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4110000
CY2014Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-418000
CY2015Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
26000
CY2014Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-43000
CY2015Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2954000
CY2014Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5087000
CY2015Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2487000
CY2014Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1639000
CY2014Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
178000
CY2015Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-833000
CY2014Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-530000
CY2015Q2 amba Increase Decrease In Deferred Tax Liabilities
IncreaseDecreaseInDeferredTaxLiabilities
-20000
CY2014Q2 amba Increase Decrease In Deferred Tax Liabilities
IncreaseDecreaseInDeferredTaxLiabilities
0
CY2015Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1301000
CY2014Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-14000
CY2015Q2 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On an ongoing basis, management evaluates its estimates and assumptions, including those related to (i)&#160;the collectability of accounts receivable; (ii)&#160;write down for excess and obsolete inventories; (iii)&#160;the estimated useful lives of long-lived assets; (iv)&#160;impairment of long-lived assets and financial instruments; (v)&#160;warranty obligations; (vi)&#160;the valuation of stock-based compensation awards and financial instruments; (vii)&#160;the probability of performance objectives achievement; (viii)&#160;the realization of tax assets and estimates of tax liabilities, including reserves for uncertain tax positions; and (ix)&#160;the recognition and disclosure of contingent liabilities. These estimates and assumptions are based on historical experience and on various other factors which the Company believes to be reasonable under the circumstances. The company may engage third-party valuation specialists to assist with estimates related to the valuation of financial instruments and assets associated with various contractual arrangements. Such estimates often require the selection of appropriate valuation methodologies and significant judgment. Actual results could differ from these estimates under different assumptions or circumstances.</p></div>
CY2015Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
40187000
CY2015Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000
CY2015Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
19000
CY2015Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
40170000
CY2015Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
40131000
CY2015Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
9000
CY2015Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
10000
CY2015Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
40130000
CY2015Q2 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
33672000
CY2015Q1 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
37559000
CY2015Q2 amba Available For Sale Securities Debt Maturities Within One To Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneToTwoYearsFairValue
6498000
CY2015Q1 amba Available For Sale Securities Debt Maturities Within One To Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneToTwoYearsFairValue
2571000
CY2015Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
18165000
CY2015Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
13805000
CY2015Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7638000
CY2015Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7888000
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9574000
CY2015Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9279000
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6552000
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6204000
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5709000
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11318000
CY2015Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
201000
CY2015Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
203000
CY2015Q2 amba Accrued Rebates
AccruedRebates
515000
CY2015Q1 amba Accrued Rebates
AccruedRebates
254000
CY2015Q2 amba Accrued Development Cost Liabilities
AccruedDevelopmentCostLiabilities
7200000
CY2015Q1 amba Accrued Development Cost Liabilities
AccruedDevelopmentCostLiabilities
5004000
CY2015Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1718000
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1920000
CY2015Q2 amba Deferred Cost Of Revenue From Product Shipments
DeferredCostOfRevenueFromProductShipments
1831000
CY2015Q1 amba Deferred Cost Of Revenue From Product Shipments
DeferredCostOfRevenueFromProductShipments
1168000
CY2015Q2 us-gaap Deferred Revenue
DeferredRevenue
6406000
CY2015Q1 us-gaap Deferred Revenue
DeferredRevenue
5105000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
66100
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5482000
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2874000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2281909
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
36.30
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
16431000
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M10D
CY2015Q2 amba Share Based Compensation Arrangement Exercisable Options Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementExercisableOptionsWeightedAverageRemainingContractualTerm
P5Y3M26D
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y3M22D
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
119790000
CY2015Q2 amba Share Based Compensation Arrangement Exercisable Options Intrinsic Value
ShareBasedCompensationArrangementExercisableOptionsIntrinsicValue
91169000
CY2015Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
272334
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5580
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2070095
CY2015Q2 amba Share Based Compensation Arrangement Exercisable Options
ShareBasedCompensationArrangementExercisableOptions
1399112
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2027575
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.00
CY2015Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
64.39
CY2015Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.88
CY2015Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
24.62
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.28
CY2015Q2 amba Share Based Compensation Arrangement Exercisable Options Weighted Average Exercise Price
ShareBasedCompensationArrangementExercisableOptionsWeightedAverageExercisePrice
7.99
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
14.84
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
118221000
CY2015Q2 amba Closing Market Price Of Ordinary Shares On Nasdaq On Last Day Of Reporting Period
ClosingMarketPriceOfOrdinarySharesOnNASDAQOnLastDayOfReportingPeriod
73.15
CY2015Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
CY2014Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
2000
CY2015Q2 amba Net Income Available To Ordinary Shareholders Basic
NetIncomeAvailableToOrdinaryShareholdersBasic
18854000
CY2014Q2 amba Net Income Available To Ordinary Shareholders Basic
NetIncomeAvailableToOrdinaryShareholdersBasic
5258000
CY2015Q2 amba Additional Undistributed Earnings Allocated To Ordinary Shareholders
AdditionalUndistributedEarningsAllocatedToOrdinaryShareholders
0
CY2014Q2 amba Additional Undistributed Earnings Allocated To Ordinary Shareholders
AdditionalUndistributedEarningsAllocatedToOrdinaryShareholders
0
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
18854000
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
5258000
CY2015Q2 amba Weighted Average Number Of Ordinary Shares Outstanding
WeightedAverageNumberOfOrdinarySharesOutstanding
31099137
CY2014Q2 amba Weighted Average Number Of Ordinary Shares Outstanding
WeightedAverageNumberOfOrdinarySharesOutstanding
28986938
CY2015Q2 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
56
CY2014Q2 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
10599
CY2015Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1397695
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2110757
CY2015Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
961284
CY2014Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
655502
CY2015Q2 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
14249
CY2014Q2 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
21395
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
84917
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
192864
CY2015Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.074
CY2014Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.120
CY2015Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4700000
CY2015Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1900000
CY2014Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1300000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
4233000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
4996000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1379000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
237000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
0
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
10845000
CY2015Q2 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
38100000
CY2015Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
27500000
CY2015Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2015Q2 amba Minimum Percentage Of Voting Stock Used To Define Related Party
MinimumPercentageOfVotingStockUsedToDefineRelatedParty
0.10

Files In Submission

Name View Source Status
0001564590-15-004907-index-headers.html Edgar Link pending
0001564590-15-004907-index.html Edgar Link pending
0001564590-15-004907.txt Edgar Link pending
0001564590-15-004907-xbrl.zip Edgar Link pending
amba-10q_20150430.htm Edgar Link pending
amba-20150430.xml Edgar Link completed
amba-20150430.xsd Edgar Link pending
amba-20150430_cal.xml Edgar Link unprocessable
amba-20150430_def.xml Edgar Link unprocessable
amba-20150430_lab.xml Edgar Link unprocessable
amba-20150430_pre.xml Edgar Link unprocessable
amba-ex311_201504306.htm Edgar Link pending
amba-ex312_201504308.htm Edgar Link pending
amba-ex321_201504307.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending